A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks. In health care,
Tag: Eli Lilly and Co
Here’s who could be next to split their stock after Chipotle
Investors are watching for which company could be next after Chipotle announced Tuesday it will split its stock 50-shares-for-1 in June. Shares
Jim Cramer shares his thoughts on TSLA, HTZ, PEP, SMCI and VRT
Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. Tesla : Shares rose 5%
Wegovy heart health approval won’t mean broad insurance coverage yet
Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a
WeightWatchers CEO just sent a memo to employees as stock crashes
Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an internal memo to
FDA approves NASH liver disease drug from Madrigal Pharmaceuticals
In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images | Lightrocket |
Stocks making the biggest moves midday: NVDA, COIN, ORCL, BALY
Check out the companies making headlines in midday trading. Bally’s — Shares soared more than 25% after hedge fund Standard General made
Eli Lilly hits another Alzheimer’s hurdle. But obesity, diabetes GLP-1s strong
Eli Lilly ‘s experimental Alzheimer’s treatment hit another hurdle with U.S. drug regulators. It pushed out the timeline for potential approval but
Novo Nordisk Wegovy approved for cutting heart disease risks
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty
Eli Lilly Alzheimer’s drug FDA approval delayed
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading
No More Posts Available.
No more pages to load.